| | 444731-52-6 Basic information More.. |
| Product Name: | Pazopanib | | Synonyms: | Pazopanib for research;Pazopanib;Pazopanib(GW786034);5-(4-((2,3-diMethyl-3,3a-dihydro-2H-indazol-6-yl)(Methyl)aMino)pyriMidin-2-ylaMino)-2-MethylbenzenesulfonaMide;5-[(4-{[(2,3-diMethyl-2H-indazol-6-yl)Methyl]aMino}pyriMidin-2-yl)aMino]-2-Methylbenzene-1-sulfonaMide;5-({4-[(2,3-diMethyl-2H-indazol-6-yl)(Methyl)aMino]pyriMidin-2-yl}aMino)-2-MethylbenzenesulfonaMide
5-(4-(N-(2,3-diMethyl-2H-indazole-6-yl)- N-MethylaMino)pyriMidine-2-ylaMino)-2-MethylbenzenesulfonaMide;GW786034; VOTRIENT;BenzenesulfonaMide, 5-[[4-[(2,3-diMethyl-2H-indazol-6-yl)MethylaMino]-2-pyriMidinyl]aMino]-2-Methyl- | | CAS: | 444731-52-6 | | MF: | C21H23N7O2S | | MW: | 437.52 | | EINECS: | 251-228-4 | | Mol File: | 444731-52-6.mol |  |
Use
Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR-α/β, and c-Kit.
- Pazopanib
-
- US $0.00-0.00 / kg
- 2024-11-26
- CAS:444731-52-6
- Min. Order: 1kg
- Purity: 99%，single impurity＜0.1
- Supply Ability: 1 ton
- Pazopanib
-
- US $42.00-97.00 / mg
- 2024-11-19
- CAS:444731-52-6
- Min. Order:
- Purity: 99.84%
- Supply Ability: 10g
- Pazopanib
-
- US $42.00-97.00 / mg
- 2024-11-19
- CAS:444731-52-6
- Min. Order:
- Purity: 99.84%
- Supply Ability: 10g
|
|
444731-52-6
Recommend Suppliers |
|